Marcela V. Maus, M.D.,Ph.D.

• Emapalumab Prevention of CAR-T Cell Associated Toxicities

  Phase 2, Recruiting, 28 people, 12 Aug 2024

• CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

  Phase 1, Recruiting, 24 people, 7 Sept 2023

• NCT04150913

  Phase 2, Completed, 15 people, 5 Nov 2019

Sources: clinicaltrials.gov